Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...

Another recent federal study, published in the journal JAMA Pediatrics in February, showed approximately 1.01 million ...

Under normal circumstances, the study of health problems after COVID vaccinations posted online on Feb. 25 might not have ...

Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

The 2020s have inarguably been Covid-19’s decade. Since the coronavirus outbreak was acknowledged as a pandemic exactly five ...

At five years since COVID-19 began sweeping through Fond du Lac, here are some stories, from lost loved ones to long-term ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...

Vaccine hesitancy and higher rates of school vaccine exemptions increases the risk of outbreaks of preventable diseases, creating a significant health risk for vulnerable populations.

Pfizer’s PFE stock has risen 5.9% in the past three months. The stock has started to show a consistent increase, with some ...

A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna .